US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 14.090
  • -0.250-1.74%
Close Nov 22 16:00 ET
  • 14.090
  • 0.0000.00%
Post 16:02 ET
363.21MMarket Cap-12546P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Contineum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--------

Unlock Free Earnings Estimates

Contineum Therapeutics Earnings Reports

  • Contineum Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:16 ET

  • Contineum Therapeutics | 8-K: Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 6 16:14 ET

  • Contineum Therapeutics | 10-Q: Quarterly report

    Aug 14 12:50 ET

  • Contineum Therapeutics | 8-K/A: Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 14 12:25 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data